Clinical presentation and outcome of nonfunctional pancreatic neuroendocrine tumors in a modern cohort

被引:5
|
作者
Watley, Duncan C. [1 ]
Ly, Quan P. [1 ,3 ]
Talmon, Geoffrey [2 ,3 ]
Are, Chandrakanth [1 ,3 ]
Sasson, Aaron R. [1 ,3 ]
机构
[1] Univ Nebraska Med Ctr, Dept Surg, Div Surg Oncol, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[3] Fred & Pamela Buffet Canc Ctr, Omaha, NE USA
来源
AMERICAN JOURNAL OF SURGERY | 2015年 / 210卷 / 06期
关键词
Pancreatic tumor; Nonfunctional pancreatic tumors; Incidental tumors; Incidental nonfunctional pancreatic tumor; Neuroendocrine tumor; Nonfunctional neuroendocrine tumor; ENDOCRINE TUMORS; PROGNOSTIC-FACTORS; FEATURES;
D O I
10.1016/j.amjsurg.2015.08.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The natural history of nonfunctional pancreatic neuroendocrine tumors (NF-PNETs) is largely unstudied due to its rarity. The primary goal of this study was to characterize clinical features and outcomes of incidental NF-PNETs. METHODS: An institutional review board-approved retrospective study of patients with NF-PNET evaluated by the Surgical Oncology of University of Nebraska Medical Center was performed. Patients were evaluated with dedicated pancreatic and liver imaging using multiphasic computed tomographic scan and dedicated magnetic resonance imaging protocols. RESULTS: Forty-six patients (male, 47.8%) were evaluated, and 35 ultimately resected. Of these, 16 tumors were discovered incidentally. The median age was 62 and 59 years in incidental and symptomatically discovered, respectively. Incidental median size was 2.4 cm vs 6 cm in the symptomatic group, with a P value of.037. The presence of lymphatic and liver metastases was 10% and 25% incidental and 45% and 67% for those with symptoms (lymphatic involvement, P = .05; liver metastases P = .07). Median overall survival was 45 and 76 months (P = .03). CONCLUSIONS: Incidentally discovered NF-PNETs represent a malignancy with more questions than answers. Our series indicates that these cancers are more indolent than previously believed. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1192 / 1195
页数:4
相关论文
共 50 条
  • [21] Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm
    Mirkin, Katelin A.
    Hollenbeak, Christopher S.
    Wong, Joyce
    JOURNAL OF SURGICAL RESEARCH, 2017, 211 : 206 - 214
  • [22] Evolving Paradigm for Managing Small Nonfunctional Incidentally Discovered Pancreatic Neuroendocrine Tumors
    Libutti, Steven K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4670 - 4672
  • [23] Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen, Ville
    Haglund, Caj
    Seppanen, Hanna
    SURGERY, 2015, 158 (06) : 1557 - 1564
  • [24] Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome
    Penitenti, F.
    Landoni, L.
    Scardoni, M.
    Piredda, M. L.
    Cingarlini, S.
    Scarpa, A.
    D'Onofrio, M.
    Girelli, D.
    Davi, M., V
    ENDOCRINE, 2021, 74 (01) : 180 - 187
  • [25] Clinical Presentation and Diagnosis of Neuroendocrine Tumors
    Vinik, Aaron I.
    Chaya, Celine
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 21 - +
  • [26] Editorial for "Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors"
    Izumiya, Masashi
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (04) : 1137 - 1138
  • [27] Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors
    Sugawara, Toshitaka
    Rodriguez Franco, Salvador
    Kirsch, Michael J.
    Colborn, Kathryn L.
    Ishida, Jun
    Grandi, Samuele
    Al-Musawi, Mohammed H.
    Gleisner, Ana
    Del Chiaro, Marco
    Schulick, Richard D.
    JAMA NETWORK OPEN, 2023, 6 (03)
  • [28] Pancreatic Neuroendocrine Tumors: a Modern Approach to Treatment
    Kuchin, D. M.
    Seregin, A. A.
    Zagainov, V. E.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2019, 11 (03) : 75 - 79
  • [29] MicroRNA Associated With Outcome in Pancreatic Neuroendocrine Tumors
    Gonzalez-Berjon, Jose
    Tetzlaff, Michael
    Yao, James
    Loose, David
    Broaddus, Russell
    Estrella, Jeannelyn
    MODERN PATHOLOGY, 2015, 28 : 442A - 443A
  • [30] MicroRNA Associated With Outcome in Pancreatic Neuroendocrine Tumors
    Gonzalez-Berjon, Jose
    Tetzlaff, Michael
    Yao, James
    Loose, David
    Broaddus, Russell
    Estrella, Jeannelyn
    LABORATORY INVESTIGATION, 2015, 95 : 442A - 443A